Yew Bio-Pharm Group, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 8.737 million compared to USD 2.029 million a year ago. Operating income was USD 2.966 million compared to USD 157,388 a year ago. Net income was USD 2.918 million compared to USD 151,412 a year ago. Basic earnings per share from continuing operations was USD 0.06.